Bilateral hila lymphadenopathy
bilateral hilar lymphadenopathy chest X-ray sarcoidosis

A posterior-anterior (PA) chest X-ray demonstrating a combination of thoracic findings. The image reveals prominent bilateral hilar lymphadenopathy (BHL), characterized by well-defined, bulky opacities in both hilar regions, consistent with Stage II sarcoidosis. Additionally, there is evidence of pulmonary edema, visualized as increased perihilar haziness and interstitial markings radiating from the central lung zones, which obscures the sharp margins of the pulmonary vasculature. The cardiac silhouette appears slightly enlarged, and there is a mild reduction in the clarity of the costophrenic angles. The musculoskeletal structures and overlying soft tissues are unremarkable. This radiographic presentation is significant for assessing systemic conditions such as cardiac sarcoidosis, where lymphadenopathy and acute congestive heart failure findings may coexist.

This diagnostic image is an anteroposterior chest X-ray demonstrating a classic presentation of bilateral hilar lymphadenopathy. The primary finding is the symmetrical enlargement of the hilar regions, appearing as lobulated, increased-density masses where the major bronchi and pulmonary vessels enter the lung parenchyma. This 'potato-node' appearance is a hallmark of pulmonary sarcoidosis. The lung fields are generally clear without obvious parenchymal infiltrates or consolidation, though the hilar margins are ill-defined due to the lymphatic enlargement. The mediastinal borders are slightly widened, but the cardiac silhouette and diaphragmatic contours remain distinguishable. The ribcage and clavicles are visualized and provide anatomical orientation. Clinically, this imaging is characteristic of Stage I sarcoidosis, often used to evaluate systemic granulomatous disease in both radiology and internal medicine education.

This diagnostic image is a posteroanterior (PA) chest X-ray illustrating classic features of stage II sarcoidosis. The primary finding is significant bilateral hilar lymphadenopathy, characterized by symmetrical enlargement and lobulated contours of both lung roots. Additionally, there is prominent soft tissue density in the left paratracheal region, indicating paratracheal lymphadenopathy. The lung parenchyma exhibits a diffuse reticulonodular pattern, with granular infiltrates most concentrated in the upper and middle lung zones bilaterally. These small, ill-defined opacities represent granulomatous inflammation within the interstitial spaces. The combination of symmetric hilar nodes and upper-lobe predominant parenchymal changes is highly characteristic of sarcoidosis. The image serves as a clinical reference for pulmonary manifestations of systemic granulomatous disease and the radiological assessment of mediastinal lymphadenopathy.

This composite diagnostic image features a posterior-anterior (PA) chest X-ray and axial chest computed tomography (CT) scans illustrating systemic sarcoidosis. (A) The chest X-ray shows bilateral, ill-defined hilar and mid-zone opacities, consistent with lymphadenopathy and pulmonary parenchymal involvement. (B) The CT scans (lung and mediastinal windows) provide detailed views of extensive mediastinal and bilateral hilar lymphadenopathy. Significant parenchymal findings include bilateral tumor-like consolidations and diffuse micronodular (granular) shadows with a perilymphatic distribution, characteristic of Stage II or III pulmonary sarcoidosis. Some lesions appear as large, dense masses mimicking malignancy, while others are small and scattered. The mediastinal window specifically highlights the conglomerate enlargement of the paratracheal and subcarinal lymph nodes. These findings, in conjunction with elevated ACE and sIL-2R levels mentioned in clinical context, demonstrate the multisystemic nature of the disease and its potential for varied radiological manifestations.
"bilateral hilar lymphadenopathy" diagnosis
| Category | Specific Conditions |
|---|---|
| Infections | Tuberculosis, histoplasmosis, coccidioidomycosis, blastomycosis, Mycobacterium avium complex, EBV (infectious mononucleosis) |
| Malignancy | Lymphoma (Hodgkin's and non-Hodgkin's), lung carcinoma with nodal spread, leukemia, metastatic disease |
| Occupational/Inhaled | Berylliosis (chronic beryllium disease), silicosis, coal dust |
| Autoimmune/Inflammatory | Hypersensitivity pneumonitis, ANCA-associated vasculitis, IgG4-related disease, rheumatoid arthritis |
| Drug-induced | Immune checkpoint inhibitors, antiretroviral therapy, interferon, TNF-α antagonists |
| Other | Amyloidosis, Castleman disease, Löfgren syndrome |
| Stage | Chest X-ray Finding | Spontaneous Remission |
|---|---|---|
| 0 | Normal | -- |
| I | BHL alone, clear lung fields | ~65-90% |
| II | BHL + parenchymal infiltrates | ~50-60% |
| III | Parenchymal infiltrates, no BHL | ~30% |
| IV | Pulmonary fibrosis | Rare |


| Indication | Agent |
|---|---|
| Mild/asymptomatic Stage I-II | Observation (many remit spontaneously) |
| Symptomatic/organ-threatening | Prednisone 20-40 mg/day (first-line) |
| Steroid-sparing / steroid failure | Methotrexate (most evidence), azathioprine, mycophenolate, leflunomide |
| Skin/hypercalcemia | Hydroxychloroquine |
| Refractory disease | Infliximab or adalimumab (anti-TNF-α) - etanercept is ineffective |